1-9 of 9
Sandra Coral
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy

Free
Maria Fortunata Lofiego, Rossella Tufano, Emma Bello, Laura Solmonese, Francesco Marzani, Francesca Piazzini, Fabrizio Celesti, Francesca Pia Caruso, Teresa Maria Rosaria Noviello, Roberta Mortarini, Andrea Anichini, Michele Ceccarelli, Luana Calabrò, Michele Maio, Sandra Coral, Anna Maria Di Giacomo, Alessia Covre
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 4841.
https://doi.org/10.1158/1538-7445.AM2025-4841
Published: 21 April 2025
View article titled, Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy
Journal Articles

Abstract 2632: A new paradigm for brain tumors treatment: Guadecitabine as a fundamental player to improve tumor immune response

Free
Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, Francesco Marzani, Laura Solmonese, Emma Bello, Fabrizio Celesti, Maria Claudia Costa, Teresa Maria Noviello, Roberta Mortarini, Andrea Anichini, Michele Ceccarelli, Sandra Coral, Anna Maria Di Giacomo, Michele Maio, Alessia Covre
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2632.
https://doi.org/10.1158/1538-7445.AM2024-2632
Published: 22 March 2024
View article titled, Abstract 2632: A new paradigm for brain tumors treatment: Guadecitabine as a fundamental player to improve tumor immune response
Journal Articles

Abstract 3273: Guadecitabine plus ipilimumab in unresectable melanoma: Five-year follow-up and correlation with integrated, multi-omic analysis in the NIBIT-M4 trial

Free
Teresa Noviello, Anna Maria Di Giacomo, Francesca Pia Caruso, Alessia Covre, Giovanni Scala, Luigi Ferraro, Sandra Coral, Wolf H. Fridman, Catherine Sautes-Fridman, Roberta Mortarini, Elena Simonetti, Maria Fortunata Lofiego, Davide Bedognetti, Andrea Anichini, Michele Ceccarelli, Michele Maio
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3273.
https://doi.org/10.1158/1538-7445.AM2023-3273
Published: 04 April 2023
View article titled, Abstract 3273: Guadecitabine plus ipilimumab in unresectable melanoma: Five-year follow-up and correlation with integrated, multi-omic analysis in the NIBIT-M4 trial
Journal Articles

Abstract 4488: Immunomodulatory activity of epigenetic drugs: Laying the ground for new combined immunotherapeutic strategies for glioblastoma

Free
Maria Fortunata Lofiego, Francesca Piazzini, Carolina Fazio, Ornella Cutaia, Carla Chiarucci, Sara Cannito, Elisabetta Gambale, Monica Valente, Anna Maria Di Giacomo, Sandra Coral, Clelia Miracco, Giuseppe Oliveri, Michele Maio, Alessia Covre
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4488.
https://doi.org/10.1158/1538-7445.AM2020-4488
Published: 15 August 2020
View article titled, Abstract 4488: Immunomodulatory activity of epigenetic drugs: Laying the ground for new combined immunotherapeutic strategies for glioblastoma
Journal Articles

Abstract CT270: A randomized, multi-center, phase II study of nivolumab combined with ipilimumab and guadecitabine or nivolumab combined with ipilimumab in melanoma and NSCLC patients resistant to anti-PD-1/-PD-L1: The NIBIT-ML1 Study

Free
Anna Maria Di Giacomo, Luana Calabrò, Riccardo Danielli, Monica Valente, Elisabetta Gambale, Sandra Coral, Giovanni Amato, Harold Keer, Diana Giannarelli, Mohammad Azab, Andrea Anichini, Alessia Covre, Michele Maio
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT270.
https://doi.org/10.1158/1538-7445.AM2020-CT270
Published: 15 August 2020
View article titled, Abstract CT270: A randomized, multi-center, phase II study of nivolumab combined with ipilimumab and guadecitabine or nivolumab combined with ipilimumab in melanoma and NSCLC patients resistant to anti-PD-1/-PD-L1: The NIBIT-ML1 Study
Journal Articles

Abstract 2325: Immune checkpoint(s) expression in AML patients enrolled in a phase 1-2 study with guadecitabine

Free
Carolina Fazio, Alessia Covre, Maria Lofiego, Pietro Taverna, Mohammad Azab, James N. Lowder, Sandra Coral, Michele Maio
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2325.
https://doi.org/10.1158/1538-7445.AM2016-2325
Published: 15 July 2016
View article titled, Abstract 2325: Immune checkpoint(s) expression in AML patients enrolled in a phase 1-2 study with guadecitabine
Journal Articles

Abstract 680: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent, in hematologic malignancies.

Free
Alessia Covre, Giulia Parisi, Hugues Jmg Nicolay, Ester Fonsatti, Elisabetta Fratta, Luca Sigalotti, Pietro Taverna, Sandra Coral, Michele Maio
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 680.
https://doi.org/10.1158/1538-7445.AM2013-680
Published: 15 April 2013
View article titled, Abstract 680: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent, in hematologic malignancies.
Journal Articles

5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story

Free
Sandra Coral, Luca Sigalotti, Alessia Covre, Hugues J.M. Nicolay, Pier Giorgio Natali, Michele Maio
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2900.
https://doi.org/10.1158/0008-5472.CAN-06-2986
Published: 15 March 2007
View article titled, 5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story
Open the PDF for 5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story in another window
Journal Articles

Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine

Free
Luca Sigalotti, Elisabetta Fratta, Sandra Coral, Silvia Tanzarella, Riccardo Danielli, Francesca Colizzi, Ester Fonsatti, Catia Traversari, Maresa Altomonte, Michele Maio
Journal: Cancer Research
Cancer Res (2004) 64 (24): 9167–9171.
https://doi.org/10.1158/0008-5472.CAN-04-1442
Published: 16 December 2004
View article titled, Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine
Open the PDF for Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine in another window